资讯

Optiscan software breakthrough will bring pathologists to the bedside
Optiscan Imaging’s new cloud software will let pathologists review high-res tissue scans in real time from anywhere, ...
Targeted Oncology10 天
AI Boosts Pathologist Accuracy in HER2-Low Breast Cancer
AI-assisted training notably improved pathologist accuracy in HER2-low breast cancer, reducing misclassification and ...
MedPage Today on MSN10 天
AI Assistance May Boost Accuracy of HER2-Low Scoring for Breast Cancers
CHICAGO -- Artificial intelligence (AI) assistance appeared to enhance pathologists' accuracy in identifying HER2-low or ...
ascopubs.org5 天
Use of artificial intelligence–assistance software for HER2-low and HER2-ultralow IHC ...
Exploratory biomarker analysis of trastuzumab deruxtecan (T-DXd) vs physician’s choice of chemotherapy (TPC) in HER2-low/ultralow, hormone receptor–positive (HR+) metastatic breast cancer (mBC) in ...
Healio5 天
AI could improve accuracy of HER2-low, HER2-ultralow breast cancer classification
AI could help pathologists identify HER2-low and HER2-ultralow breast cancers with greater accuracy, according to findings scheduled for presentation at ASCO Annual Meeting.In a study of more than 100 ...
Cancer Therapy Advisor2 天
AI Can Reduce Misclassification of HER2-Low and HER2-Ultralow Breast Cancers
A training platform integrated with AI can help pathologists identify HER2-low and HER2-ultralow breast cancers with more accuracy, data suggest.
The American Journal of Managed Care10 天
AI Can Boost Accuracy When Classifying HER2-Low, HER2-Ultralow Breast Cancers, Findings Show
Assistance from artificial intelligence can potenially increase the number of patients eligible for treatment for HER2-low ...